These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25304067)

  • 21. Outcomes of furosemide-mannitol infusion in hospitalized patients with heart failure: an observational single-center cohort study of 122 patients.
    Turagam MK; Velagapudi P; Kalra AS; Ramalingam VS; Sinnakirouchenan R; Holley JL
    Int J Cardiol; 2011 Sep; 151(2):232-4. PubMed ID: 21703703
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction.
    Aronow WS; Kronzon I
    Am J Cardiol; 1993 Mar; 71(7):602-4. PubMed ID: 8438750
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur).
    Parrinello G; Di Pasquale P; Torres D; Cardillo M; Schimmenti C; Lupo U; Iatrino R; Petrantoni R; Montaina C; Giambanco S; Paterna S
    Am Heart J; 2012 Sep; 164(3):351-7. PubMed ID: 22980301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
    Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
    J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous Furosemide in Patients With Refractory Heart Failure.
    Lozano Bahamonde A; Escolar Pérez V; Echebarria Chousa A; Azcona Lucio A; Alfambra Vicente S; Rodríguez Rodríguez B
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):500-502. PubMed ID: 30029975
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?
    Owen DR; MacAllister R; Sofat R
    Clin Pharmacol Ther; 2015 Aug; 98(2):119-21. PubMed ID: 25786394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of long and short-acting loop diuretics on mortality in patients with chronic heart failure.
    Kasama S; Toyama T; Kurabayashi M
    Int J Cardiol; 2017 Oct; 244():242-244. PubMed ID: 28645802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High furosemide dose has detrimental effects on survival of patients with stable heart failure.
    Kapelios CJ; Kaldara E; Ntalianis A; Sousonis V; Repasos E; Sfakianaki T; Vakrou S; Pantsios C; Nanas JN; Terrovitis JV
    Hellenic J Cardiol; 2015; 56(2):154-9. PubMed ID: 25854445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Furosemide Dose Administered in the Out-of-hospital Setting on Renal Function Among Patients with Suspected Acute Decompensated Heart Failure.
    Nieves LC; Mehrtens GM; Pores N; Pickrell C; Tanis J; Satty T; Chuang M; Young TC; Merlin MA
    Prehosp Disaster Med; 2015 Feb; 30(1):38-45. PubMed ID: 25592809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
    Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
    J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine in acute decompensated heart failure: does left ventricular ejection fraction matter?
    Dalzell JR; Connolly EC
    Int J Cardiol; 2014 Jul; 174(3):739. PubMed ID: 24767136
    [No Abstract]   [Full Text] [Related]  

  • 37. Which dosing of furosemide is better in acute decompensated heart failure?
    Jalaba S; Palermo J; Budavari AI
    JAAPA; 2017 Mar; 30(3):11-12. PubMed ID: 28221314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral metolazone plus frusemide for home therapy in patients with refractory heart failure.
    Lancet; 1989 Apr; 1(8640):727-8. PubMed ID: 2564538
    [No Abstract]   [Full Text] [Related]  

  • 40. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.